If you're a current smoker considering vaping as an alternative, here's what the evidence says about realistic outcomes:
Scenario 1: Complete Switch (Smoker → Exclusive Vaper)
Expected harm reduction: 80-95% reduction in smoking-related disease risk. CO exposure drops to zero within 24 hours. Lung inflammation markers drop to ~16% of smoker levels within 4-12 weeks. Cardiovascular risk factors improve measurably. Mental health shows intermediate improvement (not as much as full nicotine cessation).
Caveat: This assumes you use FDA-authorized or regulated products, not illicit disposables with unknown contents.
Scenario 2: Dual Use (Smoker + Vaper)
Expected harm reduction: Minimal to none. Dual users typically do not reduce cigarette consumption enough to achieve meaningful risk reduction. The VapeScan study found dual users had cardiovascular outcomes closer to smokers than to exclusive vapers. Mental health outcomes for dual users are worse than either exclusive group.
Recommendation: If you're dual using, the priority is complete switching — not reducing cigarettes while adding vaping.
Scenario 3: Temporary Vaping → Full Cessation
Expected harm reduction: 100% (from smoking baseline). The Cochrane Review (2024) found e-cigarettes are more effective for cessation than NRT — 9-10 per 100 quit with e-cigarettes vs 6 per 100 with NRT. FDA-authorized devices like JUUL2 showed a 49.3% switching rate in clinical trials. The goal: use vaping as a bridge to becoming nicotine-free.
Scenario 4: Never Smoker → Vaper
Expected outcome: Net harm increase. Nicotine addiction, unknown long-term inhalation effects, and no offsetting benefit (no combustion harm to reduce). This is why youth vaping prevention is critical — the harm reduction case only applies to existing smokers.
